Lijuan Yuan

Prof. Lijuan Yuan

Virginia Polytechnic Institute and State University
+1
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in Viral Immunology
Verified
Journal Article
Closed access
FLFangning Liu
Fangning Liu
GLGuohua Li
Guohua Li
KWKe Wen
Ke Wen
TBTammy Bui
Tammy Bui
DCDianjun Cao
Dianjun Cao
Lijuan YuanLijuan Yuan
Lijuan Yuan
Previous studies of epithelial immune responses to rotavirus infection have been conducted in transformed cell lines. In this study, we evaluated a non-transformed porcine jejunum epithelial cell line (IPEC-J2) as an in-vitro model of rotavirus infection and probiotic treatment. Cell-culture-adapted porcine rotavirus (PRV) OSU strain, or human rotavirus (HRV) Wa strain, along with Lactobacillus acidophilus (LA) or Lactobacillus rhamnosus GG (LGG) were used to inoculate IPEC-J2 cells. LA or LGG treatment was applied pre- or post-rotavirus infection. We demonstrated that IPEC-J2 cells were productively infected by PRV. LA or LGG treatment of the cells did not reduce virus replication. PRV infection increased MUC3 mucin secretion. LGG treatment post-rotavirus infection reduced the mucin secretion response induced by PRV; LGG alone increased the production of membrane-associated MUC3 mucin. LA treatment prior to rotavirus infection significantly increased PRV replication and the IL-6 response to PRV infection, which is consistent with the adjuvant effect of LA. LGG treatment post-rotavirus infection downregulated the IL-6 response, confirming the anti-inflammatory effect of LGG. IPEC-J2 cells expressed toll-like receptor (TLR) 2, TLR3, and TLR9 constitutively. TLR2 expression was upregulated by LGG and peptidoglycan, corresponding to the decreased IL-6 response, indicating that the protective effect of LGG is associated with upregulation of TLR2 expression on intestinal epithelial cells. The IPEC-J2 cell model of PRV infection is a completely homologous system. It is a valuable model for studying the interactions among rotavirus-host-probiotics, and the mechanisms behind the immunomodulating effect of probiotic bacteria on innate immune responses.

1 June 2013 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Open access
MVMonica Viladomiu
Monica Viladomiu
RHRaquel Hontecillas
Raquel Hontecillas
Lijuan YuanLijuan Yuan
Lijuan Yuan
PLPinyi Lu
Pinyi Lu
JBJosep Bassaganya-Riera
Josep Bassaganya-Riera
Inflammatory bowel disease (IBD) is a debilitating and widespread immune-mediated illness characterized by excessive inflammatory and effector mucosal responses leading to tissue destruction at the gastrointestinal tract. Interactions among the immune system, the commensal microbiota and the host genotype are thought to underlie the pathogenesis of IBD. However, the precise etiology of IBD remains unknown. Diet-induced changes in the composition of the gut microbiome can modulate the induction of regulatory versus effector immune responses at the gut mucosa and improve health outcomes. Therefore, manipulation of gut microbiota composition and the local production of microbial-derived metabolites by using prebiotics, probiotics and dietary fibers is being explored as a promising avenue of prophylactic and therapeutic intervention against gut inflammation. Prebiotics and fiber carbohydrates are fermented by resident microflora into short chain fatty acids (SCFAs) in the colon. SCFAs then activate peroxisome proliferator-activated receptor (PPAR)γ, a nuclear transcription factor with widely demonstrated anti-inflammatory efficacy in experimental IBD. The activation of PPARγ by naturally ocurring compounds such as conjugated linoleic acid, pomegranate seed oil-derived punicic acid, eleostearic acid and abscisic acid has been explored as nutritional interventions that suppress colitis by directly modulating the host immune response. The aim of this review is to summarize the status of innovative nutritional interventions against gastrointestinal inflammation, their proposed mechanisms of action, preclinical and clinical efficacy as well as bioinformatics and computational modeling approaches that accelerate discovery in nutritional and mucosal immunology research.

1 June 2007 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
TNTrang V. Nguyen
Trang V. Nguyen
Lijuan YuanLijuan Yuan
Lijuan Yuan
MAMarli S.P. Azevedo
Marli S.P. Azevedo
KJKwang-Il Jeong
Kwang-Il Jeong
AGAna-Maria Gonzalez
Ana-Maria Gonzalez
LSLinda J. Saif
Linda J. Saif

1 July 1996 in Journal of General Virology
Verified
Journal Article
Closed access
LWL. A. Ward
L. A. Ward
BRB. I. Rosen
B. I. Rosen
Lijuan YuanLijuan Yuan
Lijuan Yuan
LSL. J. Saif
L. J. Saif
Gnotobiotic (Gn) pigs were orally inoculated with Wa strain (G1P1A[P8]) human rotavirus (Wa HRV) serially passaged in Gn pigs (virulent) or cell culture (attenuated) to determine the median virus infectious dose (ID50) and to assess the site of infection and type and progression of morphological lesions and clinical responses induced by these two strains in Gn pigs. The ID50 of virulent Wa HRV was ⩽ 1 f.f.u. whereas the infectivity of attenuated Wa HRV had to be determined by seroconversion and was ∼ 1.3 × 106 f.f.u. Diarrhoea developed at 13 h post-inoculation (p.i.) in pigs inoculated with ∼ 105 f.f.u. of virulent Wa HRV and correlated with the presence of viral antigen within villous epithelial cells; villous atrophy developed later at 24 h p.i. and correlated with peak faecal viral titres; recovery from disease correlated with the return of morphologically normal villi. Virus, diarrhoea and villous atrophy were not detected in pigs inoculated with ∼ 2 × 108 f.f.u. attenuated Wa HRV although HRV-specific serum antibodies were present by 7 days p.i. These findings demonstrate that virulent Wa HRV infection in Gn pigs occurs primarily within intestinal villous epithelial cells with villous atrophy developing as a sequela to infection. However, factors other than villous atrophy appear to contribute to the early stages of HRV-associated disease expression in Gn pigs. The ability of the attenuated virus to elicit virus-neutralizing serum antibodies without disease or pathology indicates promise in the use of such strains for oral immunization.

1 January 1996
Verified
Book Chapter
Closed access
PDF file
LSL. J. Saif
L. J. Saif
LWL. A. Ward
L. A. Ward
Lijuan YuanLijuan Yuan
Lijuan Yuan
BRB. I. Rosen
B. I. Rosen
TTT. L. To
T. L. To

1 July 2008 in Vaccine
Verified
Journal Article
Closed access
WZWei Zhang
Wei Zhang
MAMarli S.P. Azevedo
Marli S.P. Azevedo
KWKe Wen
Ke Wen
AGAna Gonzalez
Ana Gonzalez
LSLinda J. Saif
Linda J. Saif
Lijuan YuanLijuan Yuan
Lijuan Yuan